14/11/2023
|
Earnings brief: "
3Q23: Beat estimates to a record high
"
–
Outperform (TP Bt35)
|
25/09/2023
|
High conviction: "Share price drop is overdone" – Outperform (TP Bt35)
|
17/08/2023
|
Company update: "Better 2H23 operations" – Outperform (TP Bt35)
|
23/06/2023
|
High conviction: "Safe investment with earnings conviction" –
Outperform (TP Bt34)
|
06/06/2023
|
Company update: "Site visit: Rayong Hospital" –
Outperform (TP Bt34)
|
12/05/2023
|
Earnings brief: "1Q23: Beat market, in line with INVX" –
Outperform (TP Bt34)
|
18/04/2023
|
Company update: "Preview 1Q23: Strong int’l patient services" –
Outperform (TP Bt34)
|
03/03/2023
|
Company update: "Healthy growth in 2023" – Outperform (TP Bt34)
|
23/02/2023
|
Earnings brief: "4Q22: Beat INVX but in line with consensus" – Outperform (TP Bt34)
|
12/01/2023
|
Company update: "Earnings moved up in 4Q22F" – Outperform (TP Bt34)
|
29/11/2022
|
Company update: "Healthier operations and earnings" – Outperform (TP Bt34)
|
15/11/2022
|
Earnings brief: "3Q22: Beat on revenue, margin" – Outperform (TP Bt34)
|
27/10/2022
|
Company update: "Preview 3Q22: Up YoY and QoQ" - Outperform (TP Bt31)
|
09/09/2022
|
Company update: "Resilient; earnings trending up" – Outperform (TP Bt31)
|
15/08/2022
|
Earnings brief: "2Q22: Beat estimates" – Outperform (TP Bt31)
|
24/06/2022
|
Company update: "Price laggard against earnings uptrend" – Outperform (TP Bt30)
|
27/05/2022
|
Company update: "Expanding its wellness business" – Outperform (TP Bt30)
|
13/05/2022
|
Earnings brief: "1Q22: Beat, with record high core profit" – Outperform (TP Bt30)
|
12/04/2022
|
Company update: "Preview of 1Q22: Expect a record high" – Outperform (TP Bt28)
|
07/03/2022
|
Company update: "Healthier operations in 2022" – Outperform (TP Bt28)
|
24/02/2022
|
Earnings brief: "4Q21: Beat estimates" – Outperform (TP Bt28)
|
25/01/2022
|
Company update: "Preview 4Q21: Strong non-COVID services" – Outperform (TP Bt28)
|
|
|
|
|
FOLLOW US
SCB's Facbook INVX's Twitter